News

Search:
 Search

Latest News | 3 April 2013

Policy on Generic Abuse-Deterrent Opioids Coming Soon, Will Adopt Case-by-Case Approach

0 Likes

US Food and Drug Administration (FDA) Commissioner Margaret Hamburg told an audience of opioid abuse advocates that the agency is tantalizingly close to finalizing a policy on requiring Read More...


Latest News | 29 January 2013

Civil Rights Group Argues for Protection of Prescription Databases

0 Likes

The American Civil Liberties Union (ACLU), a constitutional and legal advocacy group, is filing a lawsuit against the Drug Enforcement Administration (DEA) in light of what it calls a constitutionally Read More...


Latest News | 8 January 2013

DEA's Regulatory Agenda Affects Pharma Supply Chain, Distribution and Disposal Regulations

0 Likes

The US Food and Drug's Administration's (FDA) Unified Agenda may have been released late last year, but it's not the only US regulatory agency with the potential to affect the medical device and Read More...


Latest News | 18 October 2012

DEA Classifies Bath Salt Chemical as Schedule I Drug After Oversight

1 Likes

The Drug Enforcement Administration (DEA) has placed methylone, a powerful stimulant and psychoactive drug most notorious for its presence in bath salts, into its Schedule I of highly restricted drugs Read More...


Latest News | 1 August 2012

Legislators, Regulators to Enhance Regulation of Anabolic Steroids

0 Likes

Legislators and regulatory officials at the Drug Enforcement Administration (DEA) are both proposing to subject anabolic steroids to more stringent controls under the Controlled Substances Act (CSA), Read More...


Latest News | 6 July 2012

DEA to Increase Supply of ADHD, Opioid Ingredients in Light of Shortages

0 Likes

The US agency in charge of setting drug production quotas for substances regulated under the Controlled Substances Act (CSA) is proposing a mid-year adjustment in its production quotas for the active Read More...


Latest News | 8 June 2012

FDA Looks to Reassess Hydrocodone Products

0 Likes

The US Food and Drug Administration (FDA) is planning to revisit a benefit:risk assessment for a powerful painkiller subject to escalating amounts of addiction and abuse after the agency was pressed Read More...


Latest News | 30 May 2012

Consumers Warned of Fake Adderall in US

0 Likes

The US Food and Drug Administration (FDA) warned consumers on 29 May of counterfeit copies of Teva Pharmaceutical Industries’ attention deficit hyperactive disorder (ADHD) drug Adderall, saying some Read More...


Latest News | 13 March 2012

US DEA Releases Fee Schedule for Chemical Registrations

0 Likes

The US Drug Enforcement Administration (DEA), a division of the US Department of Justice (DOJ), released an updated adjustment of the registration and reregistration fees associated with its Diversion Read More...


Latest News | 2 March 2012

Judge Stops Company’s Drug Shipments in Florida

0 Likes

A US District judge ordered Cardinal Health to stop shipping drugs from its Lakeland, FL, distribution center, according to a report in USA Today.The US Drug Enforcement Administration (DEA) had Read More...


1 2
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more


New Regulatory Focus Apps for iPad and iPhone